Found 6 oncology trials

A listing of oncology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

UPCC 14224: A Single-Arm, Multicenter Phase 2 Study of Neoadjuvant Pembrolizumab with Trastuzumab and Chemotherapy in Resectable HER2+ Esophagogastric Tumors

99 years and younger

All genders

Please refer to Protocol Section 2.0 (Objectives and Scientific Aims). Please refer to Protocol Section 14.0 (Biostatistics). Please refer to Protocol Section 14.0 (Biostatistics).

Learn More

LGH 2023-46: S2302 Pragmatica

99 years and younger

All genders

This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a monoclonal antibody that may prevent …

Learn More

TumorGlow in Pulmonary Metastasectomy for Sarcomas

99 years and younger

All genders

This is a phase 3, multi-center, randomized, single dose, open-label study to determine the efficacy of a single dose, 5 mg/kg of ICG (TumorGlow) used with Near Infrared (NIR) fluorescent to detect clinically significant event (CSE) for subjects with suspected metastatic sarcoma to the lung scheduled to undergo thoracic surgery …

Learn More

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

99 years and younger

All genders

The primary objective of this Phase I study is to establish the safety of adjuvant concurrent radiation therapy and immunotherapy. Safety will be based on acute grade 3 or higher pelvic radiation related toxicity. Secondary objectives are to estimate late toxicities, quality of life, locoregional and distant failure and overall …

Learn More

RADIATE-VT VAR-2022-01

99 years and younger

All genders

The principal hypothesis of the Varian CRA randomized trial is that Varian CRA is safer and provides at least equivalent efficacy compared to repeat CA for patients with high-risk refractory VT who have experienced VT recurrence after CA and are candidates for additional CA.

Learn More

Head Stabilization in Whole Brain RT

99 years and younger

All genders

To determine whether or not the 6D target is 0.5mm and 0.5deg for greater than 95% of treatment time using a robotic head holder. The primary study endpoint of the study is as follows: success will be defined as to whether or not the 6D intracranial target is 0.5mm and …

Learn More